Vascular ECE-1 mRNA expression decreases in response to estrogens

Life Sciences

Volumn 73, Issue 23, 2003, Pages 2973-2983

  Rodrigo, Manoj C ^a   Martin, Douglas S ^a   Eyster, Kathleen M ^a  

^a UNIVERSITY OF SOUTH DAKOTA   (United States)

Author keywords

Artery; Daidzein; Endothelin converting enzyme 1; Estrogen; Genistein; Mesentery; Microarray

Indexed keywords

DAIDZEIN; DEOXYCYTIDINE TRIPHOSPHATE; DNA FRAGMENT; ENDOTHELIN CONVERTING ENZYME; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; FULVESTRANT; GENISTEIN; MESSENGER RNA; PHYTOESTROGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; DRUG EFFECT; DRUG TARGETING; GENE EXPRESSION; GENE IDENTIFICATION; GENE TARGETING; MALE; MESENTERIC ARTERY; NONHUMAN; OVARIECTOMY; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA HYBRIDIZATION; VASCULARIZATION;

EID: 0141644350     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2003.05.001     Document Type: Article

References (56)

1. Akishita M., Ouchi Y., Miyoshi H., Orimo A., Kozaki K., Eto M., Ishikawa M., Kim S., Toba K., Orimo H. Estrogen inhibits endothelin-1 production and c-fos gene expression in rat aorta. Atherosclerosis. 125:1996;27-38.
2. Akiyama R., Ishida J., Nakagawa S., Ogawa H., Wantanabe S., Itoh N., Shibuya M., Fukami Y. Genistein, a specific inhibitor of tyrosine specific protein kinases. Journal of Biological Chemistry. 262:1987;5592-5595.
3. Bakir S., Mori T., Durand J., Chen Y.F., Thompson J.A., Oparil S. Estrogen-induced vasoprotection is estrogen receptor dependent: evidence from the balloon-injured rat carotid artery model. Circulation. 101:2000;2342-2344.
4. Barber D.A., Sieck G.C., Fitzpatrick L.A., Miller V.M. Endothelin receptors are modulated in association with endogenous fluctuations in estrogen. American Journal of Physiology. 271:1996;H1999-H2006.
5. Barnes S. The chemopreventive properties of soy isoflavonoids in animal models of breast cancer. Breast Cancer Research and Treatment. 46:1997;169-179.
6. Barnes S. Evolution of the health benefits of soy isoflavones. Proceedings of the Society for Experimental Biology and Medicine. 217:1998;386-392.
7. Bilsel A.S., Moini H., Tetik E., Aksungar F., Kaynak B., Ozer A. 17Beta-estradiol modulates endothelin-1 expression and release in human endothelial cells. Cardiovascular Research. 46:2000;579-584.
8. Breitkopf N.P., Eyster K.M., Williams J.L., Martin D.S. Effect of genistein injections on borderline hypertension in conscious rats. Journal of Nutrition. 130:2000;695S.
9. Davenport A.P., Kuc R.E., Mockridge J.W. Endothelin-converting enzyme in the human vasculature: evidence for differential conversion of big endothelin-3 by endothelial and smooth-muscle cells. Journal of Cardiovascular Pharmacology. 31:1998;S1-S3.
10. Davenport A.P., Kuc R.E. Cellular expression of isoforms of endothelin-converting enzyme-1 (ECE-1c, ECE-1b and ECE-1a) and endothelin-converting enzyme-2. Journal of Cardiovascular Pharmacology. 36:2000;S12-S14.
11. David F.L., Carvalho M.H., Cobra A.L., Nigro D., Fortes Z.B., Reboucas N.A., Tostes R.C. Ovarian hormones modulate endothelin-1 vascular reactivity and mRNA expression in DOCA-salt hypertensive rats. Hypertension. 38:2001;692-696.
12. Disashi T., Nonoguchi H., Iwaoka T., Naomi S., Nakayama Y., Shimada K., Tanzawa K., Tomita K. Endothelin converting enzyme-1 gene expression in the kidney of spontaneously hypertensive rats. Hypertension. 30:1997;1591-1597.
13. d'Uscio L.V., Barton M., Shaw S., Luscher T.F. Endothelin in atherosclerosis: importance of risk factors and therapeutic implications. Journal of Cardiovascular Pharmacology. 35:2000;S55-S59.
14. Eyster K.M., Boles A.L., Brannian J.D., Hansen K.A. DNA microarray analysis of gene expression markers of endometriosis. Fertility and Sterility. 77:2002;38-42.
15. Ferri C., Bellini C., Desideri G., Baldoncini R., De Siati L., Santucci A. Elevated plasma endothelin-1 levels as an additional risk factor in non-obese essential hypertensive patients with metabolic abnormalities. Diabetologia. 40:1997;100-102.
16. Folkow B. Physiological aspects of primary hypertension. Physiological Reviews. 62:1982;347-504.
17. Grantham J.A., Schirger J.A., Williamson E.E., Heublein D.M., Wennberg P.W., Kirchengast M., Muenter K., Subkowski T., Burnett J.C. Jr. Enhanced endothelin-converting enzyme immunoreactivity in early atherosclerosis. Journal of Cardiovascular Pharmacology. 31:1998;S22-S26.
18. Hayashi T., Fukuto J.M., Ignarro L.J., Chaudhuri G. Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits: implications for atherosclerosis. Proceedings of the National Academy of Sciences USA. 89:1992;11259-11263.
19. Hayashi T., Yamada K., Esaki T., Kuzuya M., Satake S., Ishikawa T., Hidaka H., Iguchi A. Estrogen increases endothelial nitric oxide by a receptor-mediated system. Biochemical and Biophysical Research Communications. 214:1995;847-855.
20. Iyer R.S., Singh G., Rebello S., Roy S., Bhat R., Vidyasagar D., Gulati A. Changes in the concentration of endothelin-1 during development of hypertensive rats. Pharmacology. 51:1995;96-104.
21. Jiang C.W., Sarrel P.M., Lindsay D.C., Poole-Wilson P.A., Collins P. Endothelium-independent relaxation of rabbit coronary artery by 17 beta-oestradiol in vitro. British Journal of Pharmacology. 104:1991;1033-1037.
22. Kedzierski R.M., Yanagisawa M. Endothelin system: the double-edged sword in health and disease. Annual Review of Pharmacology and Toxicology. 41:2001;851-876.
23. Kido T., Sawamura T., Masaki T. The processing pathway of endothelin-1 production. Journal of Cardiovascular Pharmacology. 31:1998;S13-S15.
24. Kim H., Peterson T.G., Barnes S. Mechanisms of action of the soy isoflavone genistein: emerging role for its effects via transforming growth factor beta signaling pathways. American Journal of Clinical Nutrition. 68:1998;1418S-1425S.
25. Kubo T., Ibusuki T., Chiba S., Kambe T., Fukumori R. Mitogen-activated protein kinase activity regulation role of angiotensin and endothelin systems in vascular smooth muscle cells. European Journal of Pharmacology. 411:2001;27-34.
26. Kuchan M.J., Frangos J.A. Shear stress regulates endothelin-1 release via protein kinase C and cGMP in cultured endothelial cells. American Journal of Physiology. 264:1993;H150-H156.
27. Kuiper G.G., Lemmen J.G., Carlsson B., Corton J.C., Safe S.H., van der Saag P.T., van der Burg B., Gustafsson J.A. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology. 139:1998;4252-4263.
28. Lamping K.G., Nuno D.W. Effects of 17 beta-estradiol on coronary microvascular responses to endothelin-1. American Journal of Physiology. 271:1996;H1117-H1124.
29. Levitzki A. Tyrphostins: tyrosine kinase blockers as novel antiproliferative agents and dissectors of signal transduction. Faseb Journal. 6:1992;3275-3282.
30. Levitzki A., Gazit A. Tyrosine kinase inhibition: an approach to drug development. Science. 267:1995;1782-1788.
31. Liu M.Y., Hattori Y., Fukao M., Sate A., Sakuma I., Kanno M. Alterations in EDHF-mediated hyperpolarization and relaxation in mesenteric arteries of female rats in long-term deficiency of oestrogen and during oestrus cycle. British Journal of Pharmacology. 132:2001;1035-1046.
32. Maguire J.J., Johnson C.M., Mockridge J.W., Davenport A.P. Endothelin converting enzyme (ECE) activity in human vascular smooth muscle. British Journal of Pharmacology. 122:1997;1647-1654.
33. Maguire J.J., Davenport A.P. Increased response to big endothelin-1 in atherosclerotic human coronary artery: functional evidence for up-regulation of endothelin-converting enzyme activity in disease. British Journal of Pharmacology. 125:1998;238-240.
34. Miksicek R.J. Interaction of naturally occurring nonsteroidal estrogens with expressed recombinant human estrogen receptor. Journal of Steroid Biochemistry and Molecular Biology. 49:1994;153-160.
35. Minamino T., Kurihara H., Takahashi M., Shimada K., Maemura K., Oda H., Ishikawa T., Uchiyama T., Tanzawa K., Yazaki Y. Endothelin-converting enzyme expression in the rat vascular injury model and human coronary atherosclerosis. Circulation. 95:1997;221-230.
36. Muller L., Valdenaire O., Barret A., Korth P., Pinet F., Corvol P., Tougard C. Expression of the endothelin-converting enzyme-1 isoforms in endothelial cells. Journal of Cardiovascular Pharmacology. 36:2000;S15-S18.
37. Nathan L., Chaudhuri G. Estrogens and atherosclerosis. Annual Review of Pharmacology and Toxicology. 37:1997;477-515.
38. Paech K., Webb P., Kuiper G.G., Nilsson S., Gustafsson J., Kushner P.J., Scanlan T.S. Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites. Science. 277:1997;1508-1510.
39. Polderman K.H., Stehouwer C.D., van Kamp G.J., Dekker G.A., Verheugt F.W., Gooren L.J. Influence of sex hormones on plasma endothelin levels. Annals of Internal Medicine. 118:1993;429-432.
40. Rodrigo M.C., Martin D.S., Redetzke R.A., Eyster K.M. A method for the extraction of high-quality RNA and protein from single small samples of arteries and veins preserved in RNAlater. Journal of Pharmacological and Toxicological Methods. 47:2002;87-92.
41. Russell F.D., Skepper J.N., Davenport A.P. Endothelin peptide and converting enzymes in human endothelium. Journal of Cardiovascular Pharmacology. 31:1998;S19-S21.
42. Sauro M.D., Sudakow R., Burns S. In vivo effects of angiotensin II on vascular smooth muscle contraction and blood pressure are mediated through a protein tyrosine kinase-dependent mechanism. Journal of Pharmacology and Experimental Therapeutics. 277:1996;1744-1750.
43. Selzman C.H., Turner A.S., Johnson S.M., Cain B.S., Harken A.H., Whitehill T.A. Chronic estrogen replacement inhibits aortic intimal hyperplasia independent of serum lipids. Journal of Cardiovascular Surgery. 12:1997;228-234.
44. Selzman C.H., Gaynor J.S., Turner A.S., Whitehill T.A., Horwitz L.D., Harken A.H. Estrogen replacement inhibits intimal hyperplasia and the accumulation and effects of transforming growth factor beta 1. Journal of Surgical Research. 80:1998;380-385.
45. Selzman C.H., McIntyre R.C. Jr., Shames B.D., Whitehill T.A., Banerjee A., Harken A.H. Interleukin-10 inhibits human vascular smooth muscle proliferation. Journal of Molecular and Cellular Cardiology. 30:1998;889-896.
46. Smirnov S.V., Aaronson P.I. Inhibition of vascular smooth muscle cell K + currents by tyrosine kinase inhibitors genistein and ST 638. Circulation Research. 76:1995;310-316.
47. Turner A.J., Murphy L.J. Molecular pharmacology of endothelin converting enzymes. Biochemical Pharmacology. 51:1996;91-102.
48. Turner A.J., Barnes K., Schweizer A., Valdenaire O. Isoforms of endothelin-converting enzyme: why and where? Trends in Pharmacological Science. 19:1998;483-486.
49. Valdenaire O., Rohrbacher E., Mattei M.G. Organization of the gene encoding the human endothelin-converting enzyme (ECE-1). Journal of Biological Chemistry. 270:1995;29794-29798.
50. Wang T.T., Sathyamoorthy N., Phang J.M. Molecular effects of genistein on estrogen receptor mediated pathways. Carcinogenesis. 17:1996;271-275.
51. Washburn S., Burke G.L., Morgan T., Anthony M. Effect of soy protein supplementation on serum lipoproteins, blood pressure, and menopausal symptoms in perimenopausal women. Menopause. 6:1999;7-13.
52. Weiner C.P., Lizasoain I., Baylis S.A., Knowles R.G., Charles I.G., Moncada S. Induction of calcium-dependent nitric oxide synthases by sex hormones. Proceedings of the National Academy of Science USA. 91:1994;5212-5216.
53. Weisinger G., Gavish M., Mazurika C., Zinder O. Transcription of actin, cyclophilin and glyceraldehyde phosphate dehydrogenase genes: tissue- and treatment-specificity. Biochimica Biophysica Acta. 1446:1999;225-232.
54. White R.E., Darkow D.J., Lang J.L.F. Estrogen relaxes coronary arteries by opening BKCa channels through a cGMP-dependent mechanism. Circulation Research. 77:1995;936-942.
55. 2+-activated K+ channels in human coronary artery smooth muscle cells. Cardiovascular Research. 53:2002;650-661.
56. Woods M., Mitchell J.A., Wood E.G., Barker S., Walcot N.R., Rees G.M., Warner T.D. Endothelin-1 is induced by cytokines in human vascular smooth muscle cells: evidence for intracellular endothelin-converting enzyme. Molecular Pharmacology. 55:1999;902-909.